Clinical trial
Gabapentin for the Treatment of Tinnitus
NCT00317850 · Washington University School of Medicine, Other · Terminated
Key facts
| NCT number | NCT00317850 |
|---|---|
| Title | Gabapentin for the Treatment of Tinnitus |
| Official title | Gabapentin for the Relief of Idiopathic Subjective Tinnitus |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | National Institute on Deafness and Other Communication Disorders (NIDCD) NIH |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Tinnitus |
| Intervention type | Drug |
| Interventions | Gabapentin (Neurontin) |
| Enrollment | 160 |
| Start date | Apr 1, 2004 |
| Completion | Feb 1, 2006 |
| First posted | Apr 25, 2006 |
| Last update posted | Mar 2, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: